← Back to Search

Behavioral Intervention

Decision-Making Program for Dementia in Nursing Homes (DIGNITY Trial)

N/A
Waitlist Available
Led By Liza Behrens, PhD
Research Sponsored by Penn State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks after baseline education on dignity protocol
Awards & highlights

DIGNITY Trial Summary

This trial seeks to improve care and activity preferences for nursing home residents living with dementia, especially in rural and under-resourced communities.

Who is the study for?
This trial is for nursing homes in rural Pennsylvania committed to person-centered care, with a dedicated dementia unit or at least 50 beds. They must have the ability to engage in study activities throughout the term, possess a regular quality improvement team, and stable internet for program delivery.Check my eligibility
What is being tested?
The DIGNITY program is being tested to see if it helps staff in under-resourced rural nursing homes honor the care preferences of residents with dementia. It focuses on safe decision-making that supports autonomy and dignity within these communities.See study design
What are the potential side effects?
Since this intervention involves staff training and procedural changes rather than medical treatments, traditional side effects are not applicable. However, there may be challenges adapting new practices which could temporarily affect daily operations.

DIGNITY Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks after baseline education on dignity protocol
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks after baseline education on dignity protocol for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Intervention Feasibility
Intervention Fidelity
Resident Satisfaction
+1 more
Secondary outcome measures
Intervention Acceptability
Staff Self - Efficacy

DIGNITY Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: DIGNITY InterventionExperimental Treatment1 Intervention
Nursing homes randomized to this arm of the study receive an evidence based risk assessment and care planning protocol for supporting decision making and aging in dementia for autonomy (DIGNITY). Nursing home staff use this manual to implement risk assessment and care planning for resident preferences that they perceive to carry a risk to the resident's health and/or safety. In addition nursing home staff participate in Extension for Community Healthcare Outcomes (ECHO) sessions via real-time interactive videoconferencing software to support the implementation of the DIGNITY protocol.
Group II: Infection Control TrainingActive Control1 Intervention
Nursing homes randomized to this arm of the study receive CDC guidelines and evidence based information on infection prevention prevention and control. Nursing home staff implement these standard in everyday resident care. Additionally, nursing home staff are invited to participate in Extension for Community Healthcare Outcomes (ECHO) sessions via real-time interactive videoconferencing software to support the implementation of the CDC guidelines and evidence-based practices.

Find a Location

Who is running the clinical trial?

Penn State UniversityLead Sponsor
355 Previous Clinical Trials
125,753 Total Patients Enrolled
Liza Behrens, PhDPrincipal InvestigatorPenn State University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the aggregate number of individuals engaged in this medical experiment?

"Affirmative. As indicated on clinicaltrials.gov, this study is actively seeking out participants and was initially published on January 24th 2023. The manuscript has been edited most recently on September 27th 2023 with the goal of recruiting 4 individuals from 1 medical site."

Answered by AI

Is there an opportunity for participants to join this experiment currently?

"Clinicaltrials.gov confirms this investigation is actively seeking participants; the trial was first posted on January 24th 2023 and last modified on September 27th of that same year."

Answered by AI
~0 spots leftby May 2024